The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
Retinal diseases, which can lead to significant vision loss, are complex conditions involving various cellular and molecular mechanisms. The interleukin-6 (IL-6) family, particularly Oncostatin M (OSM), has garnered attention for their roles in retinal inflammation, angiogenesis, and neuroprotection...
Saved in:
| Main Authors: | Mori Tommaso, Nagaraj Nareshkumar Ragavachetty, Surico Pier Luigi, Zhou Wenjing, Parmar Uday Pratap Singh, D’Esposito Fabiana, Gagliano Caterina, Musa Mutali, Zeppieri Marco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2024-12-01
|
| Series: | Open Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/biol-2022-1023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of oncostatin M in microenvironment regulation and metastasis of breast cancer
by: CHEN Wangcheng, et al.
Published: (2025-03-01) -
Oncostatin M enhances the lengthening of sensory nerves and skin hypersensitivity
by: Chie Ishikawa, et al.
Published: (2025-07-01) -
Oncostatin M [OSM] protein immuno-expression in oral squamous cell carcinoma – A prospective study
by: Sunil Prakash, et al.
Published: (2024-06-01) -
Oncostatin M Drives Th2 Polarized Allergic Airway Inflammation Through Fibroblast Reprogramming and Endoplasmic Reticulum Stress
by: Zhang H, et al.
Published: (2025-07-01) -
Naringenin, a Food Bioactive Compound, Reduces Oncostatin M Through Blockade of PI3K/Akt/NF-κB Signal Pathway in Neutrophil-like Differentiated HL-60 Cells
by: Na-Ra Han, et al.
Published: (2025-01-01)